Nelson Leung

36.4k total citations · 4 hit papers
435 papers, 15.4k citations indexed

About

Nelson Leung is a scholar working on Molecular Biology, Hematology and Nephrology. According to data from OpenAlex, Nelson Leung has authored 435 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 268 papers in Molecular Biology, 179 papers in Hematology and 152 papers in Nephrology. Recurrent topics in Nelson Leung's work include Amyloidosis: Diagnosis, Treatment, Outcomes (223 papers), Multiple Myeloma Research and Treatments (141 papers) and Renal Diseases and Glomerulopathies (108 papers). Nelson Leung is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (223 papers), Multiple Myeloma Research and Treatments (141 papers) and Renal Diseases and Glomerulopathies (108 papers). Nelson Leung collaborates with scholars based in United States, Canada and France. Nelson Leung's co-authors include Angela Dispenzieri, Morie A. Gertz, Samih H. Nasr, Martha Q. Lacy, Shaji Kumar, Suzanne R. Hayman, Francis K. Buadi, Fernando C. Fervenza, Robert A. Kyle and Sanjeev Sethi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Nelson Leung

409 papers receiving 15.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

2013 957 citations Shaji Kumar, Angela Dispenzieri et al. Leukemia profile →
Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

2012 730 citations Shaji Kumar, Angela Dispenzieri et al. Journal of Clinical Oncology profile →
Cisplatin nephrotoxicity: a review of the literature

2017 502 citations Nelson Leung et al. profile →
Glomerulonephritis: immunopathogenesis and immunotherapy

2023 86 citations Hans‐Joachim Anders, A. Richard Kitching et al. Nature reviews. Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nelson Leung United States	65	9.6k	5.2k	5.1k	3.2k	3.1k	435	15.4k
Martha Q. Lacy United States	78	16.8k 1.7×	15.8k 3.0×	2.0k 0.4×	9.4k 2.9×	5.2k 1.7×	554	25.4k
Rafaël Fonseca United States	84	16.2k 1.7×	17.5k 3.4×	708 0.1×	9.9k 3.1×	5.8k 1.8×	441	25.8k
Peter Hillmen United Kingdom	64	2.2k 0.2×	6.6k 1.3×	3.9k 0.8×	2.3k 0.7×	14.2k 4.5×	346	22.5k
Heinz Ludwig Austria	65	6.9k 0.7×	10.8k 2.1×	281 0.1×	8.0k 2.5×	2.6k 0.8×	372	16.8k
Nicole Casadevall France	51	3.4k 0.4×	5.5k 1.1×	406 0.1×	1.3k 0.4×	4.5k 1.4×	167	10.5k
Mario Cazzola Italy	73	9.2k 1.0×	17.6k 3.4×	302 0.1×	2.3k 0.7×	15.1k 4.8×	428	25.3k
Sundar Jagannath United States	76	10.7k 1.1×	13.9k 2.7×	274 0.1×	10.8k 3.4×	2.4k 0.8×	626	21.2k
Pierre Fenaux France	90	15.7k 1.6×	27.8k 5.4×	274 0.1×	5.3k 1.7×	11.4k 3.6×	869	36.8k
Cezary Szczylik Poland	54	14.1k 1.5×	1.1k 0.2×	603 0.1×	8.1k 2.5×	841 0.3×	322	23.8k
Ronald S. Go United States	44	1.8k 0.2×	2.0k 0.4×	288 0.1×	2.5k 0.8×	1.4k 0.4×	362	7.3k

Countries citing papers authored by Nelson Leung

Since Specialization

Citations

This map shows the geographic impact of Nelson Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nelson Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nelson Leung more than expected).

Fields of papers citing papers by Nelson Leung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nelson Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nelson Leung. The network helps show where Nelson Leung may publish in the future.

Co-authorship network of co-authors of Nelson Leung

This figure shows the co-authorship network connecting the top 25 collaborators of Nelson Leung. A scholar is included among the top collaborators of Nelson Leung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nelson Leung. Nelson Leung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vaxman, Iuliana, Shaji Kumar, Angela Dispenzieri, et al.. (2024). Autologous stem cell transplantation for multiple myeloma patients whose myeloma‐defining event was SLiM. British Journal of Haematology. 206(2). 607–614. 1 indexed citations

Vaughan, Lisa E., et al.. (2024). Incidence of acute kidney injury in patients with relapsed and refractory multiple myeloma treated with teclistamab vs chimeric antigen receptor T-cell therapy.. Journal of Clinical Oncology. 42(16_suppl). 7542–7542. 2 indexed citations

Anders, Hans‐Joachim, A. Richard Kitching, Nelson Leung, & Paola Romagnani. (2023). Glomerulonephritis: immunopathogenesis and immunotherapy. Nature reviews. Immunology. 23(7). 453–471. 86 indexed citations breakdown →

Leung, Nelson, et al.. (2023). First report of teclistamab in a patient with relapsed AL amyloidosis and multiple myeloma. SHILAP Revista de lepidopterología. 4(4). 1157–1159. 4 indexed citations

Visram, Alissa, Suzanne R. Hayman, Angela Dispenzieri, et al.. (2023). A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL). American Journal of Hematology. 98(8). 1277–1285. 1 indexed citations

Khaled, Samer K., Jaap Jan Boelens, Mitchell S. Cairo, et al.. (2021). Narsoplimab (OMS721), a Masp-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA). Transplantation and Cellular Therapy. 27(3). S24–S26. 2 indexed citations

Herrmann, Sandra M., et al.. (2021). Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction. SHILAP Revista de lepidopterología. 5(3). 670–674. 16 indexed citations

Visram, Alissa, Celine M. Vachon, Linda B. Baughn, et al.. (2021). Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis. Leukemia. 36(4). 1058–1065. 4 indexed citations

Ho, Matthew, Saurabh Zanwar, Prashant Kapoor, et al.. (2021). The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM). Blood Cancer Journal. 11(9). 158–158. 6 indexed citations

10.

Sidana, Surbhi, Eli Muchtar, M Hasib Sidiqi, et al.. (2020). Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis. American Journal of Hematology. 95(5). 497–502. 32 indexed citations

11.

Klomjit, Nattawat, Nelson Leung, Fernando C. Fervenza, Sanjeev Sethi, & Ladan Zand. (2020). Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal Gammopathy. Journal of the American Society of Nephrology. 31(10). 2400–2411. 42 indexed citations

12.

Sidana, Surbhi, Nidhi Tandon, Morie A. Gertz, et al.. (2019). Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis. British Journal of Haematology. 185(4). 701–707. 14 indexed citations

13.

Sidana, Surbhi, M Hasib Sidiqi, Angela Dispenzieri, et al.. (2019). Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis. American Journal of Hematology. 94(9). 1020–1026. 31 indexed citations

14.

Saba, Elias S., et al.. (2018). Clinical Associations, Treatment, and Outcomes of Renal-Limited Thrombotic Microangiopathy. Blood. 132(Supplement 1). 4978–4978. 7 indexed citations

15.

Chakraborty, Rajshekhar, Eli Muchtar, Shaji Kumar, et al.. (2018). Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation. British Journal of Haematology. 182(1). 71–77. 12 indexed citations

16.

Leung, Nelson, Shaji Kumar, Siobhán Glavey, et al.. (2015). The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation. Nephrology Dialysis Transplantation. 31(8). 1284–1289. 22 indexed citations

17.

Kapoor, Prashant, Shaji Kumar, Angela Dispenzieri, et al.. (2013). Importance of Achieving Stringent Complete Response After Autologous Stem-Cell Transplantation in Multiple Myeloma. Journal of Clinical Oncology. 31(36). 4529–4535. 120 indexed citations

18.

Dispenzieri, Angela, Morie A. Gertz, Martha Q. Lacy, et al.. (2013). Therapeutic Strategies For Initial Treatment Of AL Amyloidosis: Implications Of Therapy and Response On Outcome. Blood. 122(21). 3343–3343. 2 indexed citations

19.

Leung, Nelson, et al.. (2012). A knowledge management methodology to enhance learning experience of undergraduate and postgraduate coursework students. Swinburne Research Bank (Swinburne University of Technology). 1 indexed citations

20.

Kumar, Shaji, Angela Dispenzieri, Jerry A. Katzmann, et al.. (2010). Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features. Blood. 116(24). 5126–5129. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact